[Vasoconstrictors in the treatment of hepatorenal syndrome]

Nefrologia. 2002:22 Suppl 5:56-61.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic alpha-Agonists / therapeutic use
  • Albumins / administration & dosage
  • Albumins / therapeutic use
  • Drug Evaluation
  • Drug Therapy, Combination
  • Hepatorenal Syndrome / classification
  • Hepatorenal Syndrome / diagnosis
  • Hepatorenal Syndrome / drug therapy*
  • Hepatorenal Syndrome / etiology
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / physiopathology
  • Lypressin / analogs & derivatives
  • Lypressin / therapeutic use
  • Midodrine / administration & dosage
  • Midodrine / therapeutic use
  • Octreotide / therapeutic use
  • Ornipressin / therapeutic use
  • Pilot Projects
  • Renal Circulation / drug effects
  • Terlipressin
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Adrenergic alpha-Agonists
  • Albumins
  • Vasoconstrictor Agents
  • Ornipressin
  • Lypressin
  • Midodrine
  • Terlipressin
  • Octreotide